Skip to main content

Table 3 Disease severity index of sepsis in patients with various AF statuses

From: Prognostic impact of restored sinus rhythm in patients with sepsis and new-onset atrial fibrillation

 

Overall patients (n = 503)

P value

No NeOAF (n = 263)

NeOAF to SR (n = 165)

NeOAF to AF (n = 75)

Infection site, n (%)

 Respiratory tract

168 (63.9)

112 (67.9)

48 (64.0)

 

 Urinary tract

57 (21.7)

35 (21.2)

14 (18.7)

 

 Gastrointestinal

23 (8.7)

9 (5.5)

5 (6.7)

 

 Others

15 (5.7)

9 (5.5)

8 (10.7)

 

SOFA score

7.0 ± 3.2

7.6 ± 3.0

9.3 ± 3.2bc

<0.01

APACHE II score

21.6 ± 5.5

22.8 ± 5.8

24.6 ± 6.1b

<0.01

Total organ failurea, n

2 (1–3)

2 (1–3)

3 (2–4)

 

 Neurologic failure

87 (33.1)

49 (29.7)

39 (52.0)bc

<0.01

 Circulatory failure

118 (44.9)

82 (49.7)

57 (76.0)bc

<0.01

 Respiratory failure

229 (87.1)

150 (90.9)

71 (94.7)

0.13

 Hepatic failure

8 (3.0)

4 (2.4)

8 (10.7)bc

<0.01

 Renal failure

86 (32.7)

65 (39.4)

39 (52.0)b

<0.01

 Hematologic failure

9 (3.4)

5 (3.0)

4 (5.3)

0.66

Vasopressor use, n (%)

 Dopamine use

95 (36.3)

64 (38.8)

49 (65.3)bc

<0.01

 Norepinephrine use

80 (30.4)

58 (35.2)

48 (64.0)bc

<0.01

Intervention, n (%)

 Ventilator use

221 (84.0)

143 (86.7)

69 (92.0)

0.21

 New-onset dialysis

50 (19.0)

35 (21.2)

19 (25.3)

0.48

  1. NeOAF new-onset atrial fibrillation, AF atrial fibrillation, SR sinus rhythm SOFA Sequential Organ Failure Assessment score, APACHE II Acute Physiology and Chronic Health Evaluation II. aTotal organ failure is presented as median and interquartile range. b P < 0.05 vs. no NeOAF. c P < 0.05 vs. NeOAF to SR